Levobens

Levodopa/Benserazide, the active ingredient in Levobens, is a dopamine precursor presented as a tablet oral formulation for oral use. It works by delivering levodopa, which is converted to dopamine in the brain, while benserazide blocks its peripheral breakdown, thereby treating the motor symptoms of Parkinson's disease in adult patients.

GNH USA supplies Levobens as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across global markets through robust distribution networks.

Levobens, a combination of levodopa and benserazide, is used in the management of Parkinsonian disorders.

Parkinson's disease: improves motor symptoms such as tremor, rigidity, and bradykinesia.

Levodopa/benserazide may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Nausea: upset stomach often occurring after dose initiation. - Orthostatic hypotension: dizziness upon standing. - Dyskinesia: involuntary movements with chronic use. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Severe psychiatric disturbances: hallucinations or psychosis. - Cardiac arrhythmias: irregular heart rhythm requiring monitoring.

When prescribing Levobens, several safety considerations should be observed. - Renal or hepatic impairment: adjust monitoring as metabolism may be affected. - Cardiovascular disease: monitor blood pressure due to orthostatic effects. - Psychiatric history: watch for hallucinations or confusion. - Concomitant MAO‑B inhibitors: avoid due to risk of hypertensive crisis. - Pregnancy and lactation: use only if benefit outweighs risk, as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Levobens can interact with several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may cause hypertensive crisis. - Antipsychotics (e.g., haloperidol): reduce levodopa efficacy. - High‑dose pyridoxine (vitamin B6): increases peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive effect on blood pressure. - SSRIs or SNRIs: may increase risk of serotonin syndrome. - Iron or calcium supplements: decrease levodopa absorption if taken simultaneously.